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Abstract
Iron uptake by the ubiquitous iron storage protein, ferritin, involves the oxidation of 
two Fe(II) ions located at the highly conserved dinuclear "ferroxidase centre" in individual 
subunits. We have measured X-ray absorption spectra (XAS) of four mutants (K86Q, 
K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on 
either or both sides of the dinuclear ferroxidase site) of recombinant Human H-chain ferritin 
(rHuHF) in their complexes with reactive Fe(II) and redox-inactive Zn(II). The results for Fe- 
rHuHf are compared with recombinant Desulfovibrio desulfuricans bacterioferritin (DdBfr) in 
three states: oxidised, reduced, and oxidised/Chelex®-treated. The X-ray absorption near edge 
region of the spectrum (XANES) allows the oxidation state of the Fe ions to be assessed. 
Extended X-ray absorption fine structure (EXAFS) simulations have yielded accurate 
geometric information that represents an important refinement of the crystal structure of 
DdBfr; most metal-ligand bonds are shortened and there is a decrease in ionic radius going
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from the Fe(II) to the Fe(III) state. The Chelex®-treated sample is found to be partly 
mineralized, giving an indication of the state of Fe in the cycled-oxidised (reduced, then 
oxidised) form of DdBfr, where the crystal structure shows the dinuclear site to be only half­
occupied. In the case of rHuHF the complexes with Zn(II) reveal a surprising similarity 
between the variants, indicating that the rHuHf dinuclear site is rigid. In spite of this, the 
rHuHf complexes with Fe(II) show a variation in reactivity that is reflected in the Fe 
oxidation states and coordination geometries.
Introduction
Ferritins are ubiquitous proteins that concentrate, store, and detoxify intracellular iron. 
They do this by catalysing the oxidation of Fe(II) at dinuclear ferroxidase centres: the Fe(III) 
then migrates to nucleation sites within the internal protein cavity, where it is deposited as an 
inorganic mineral phase. Ferritins are widespread in nature, being found in bacteria and 
archaea as well as in eukaryotes. Their molecules are mostly assemblies of 24 structurally 
equivalent subunits related by octahedral 432 symmetry which form a nearly spherical shell of 
~ 480 kDa with an 80 Â diameter iron storage cavity in which up to 4500 iron ions can be 
accumulated. The protein subunits are folded in compact, four-helix bundles [1].
Most vertebrate ferritins are formed from two different subunits, H and L, although 
amphibians have a third subunit, M. The conserved residues essential for the ferroxidase 
activity, Glu27, Tyr34, Glu61, Glu62, His65, Glu107, and Gln141 (Human H-chain 
numbering) are found only in H-type ferritins [2-4]. Crystal structures of the metal centre in 
recombinant (K86Q, for ease of crystallisation) Human H-type ferritin (rHuHF) [5] and in 
Escherichia coli [6] have been reported (see Figure 1A for a schematic representation of the
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protein ligands). The di-iron centres in animal H ferritins are relatively labile and the iron 
could move from the dinuclear site into the iron storage cavity upon oxidation, in line with the 
aforementioned mechanism of uptake as Fe(II) and storage as Fe(III). In order to avoid this, 
Zn(II) has been used as a redox-stable alternative to Fe(II) [7] and recently some of us 
reported crystal structures of the Zn derivatives of rHuHF and some other variants [8].
- - - FIGURE 1 - - -
Bacterioferritins differ from mammalian-type ferritins in terms of amino acid 
sequence, immunological cross reactivity, composition of the iron core and particularly by the 
presence of one haem group per subunit dimer. The bacterioferritin from the anaerobic 
sulphate/nitrate reducer Desulfovibrio desulfuricans (DdBfr) has in its native form a fully 
occupied diiron ferroxidase centre (see Figure 1B for a schematic representation), but without 
a central ferrihydrite core. When isolated from the bacterium under anaerobic conditions it has 
a total of 60 Fe atoms/ protein molecule, consisting of 24 di-iron centres and 12 haem irons, 
as shown in the crystal structure [9]. However, although iron in DdBfr is found in the di-iron 
centre, in principle a larger amount of iron can be stored inside the cavity of the protein.
With its large core full of iron, ferritin was an obvious target for early biological 
EXAFS studies [10]. More ambitious studies in which apoferritin was reconstituted with just 
enough iron to fill the dinuclear ferroxidase site, resulting in samples much more dilute in 
iron, followed later [11]. EXAFS was also used to compare the ferritin core to accurate 
synthetic models [12]. In a recent stopped-flow EXAFS study on the HuHF ferroxidase site, 
evidence was presented for intermediates with Fe-Fe distances as short as 2.5 Â in the 
reaction of the bis-Fe(II) site with oxygen [13]. In order to evaluate the importance of the
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distance between the iron ions in the ferroxidase centre in rHuHF for the reactivity, we have 
constructed HuHF site directed mutants in which the Glu residues on either side of the 
dinuclear iron site, Glu-107 or Glu-27, alone or together, are substituted by Asp. All Human 
ferritin proteins studied in this work contained the Lys86 to Gln substitution to allow 
crystallisation [5]; for convenience the reference protein rHuHF-K86Q, is referred to as the 
“wild type” rHuHF, and the other mutants, in which one or more Glu residues have been 
mutated in addition to the K86Q mutation, are named rHuHF-E107D, rHuHF-E27D, and 
rHuHF-E107D/E27D. We have recently reported the crystal structures of the recombinant 
apoproteins and Zn complexes [8]. In the present study, the Fe in the ferroxidase sites of these 
rHuHF mutants and the Zn in their Zn(II) derivatives are compared with the Fe in the 
relatively stable dinuclear ferroxidase site in DdBfr by XAS. The DdBfr used in this EXAFS 
study is not the wild type DdBfr studied by crystallography [9], but a recombinant produced 
in E. coli into which the di-iron (ferroxidase) centre has been reconstituted with Fe and the 
haem cofactor is absent. The Zn EXAFS results show that the rHuHF mutants are remarkably 
similar in structure, but the Fe EXAFS reveals differences in reactivity. The DdBfr results 
show that the Fe-ligand distances are shorter than in the crystallographic study, that the Fe ion 
in the reduced state has an ionic radius which is significantly larger than that in the other 
states, in line with reduction from Fe(III) to Fe(II), and that the iron in a Fe-containing protein 
sample that has been exposed to air is at least partly mineralized.
Materials and methods
Cloning, overexpression and purification o f  bacterioferritin (DdBfr). For expression 
purposes, homologous oligonucleotides that allowed the introduction in the Bfr gene of an 
NdeI restriction site, at the start codon, and a BamHI restriction site, downstream of the stop
5
12
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
codon, were designed. By means of a PCR reaction, using the oligonucleotides, Pfu 
polymerase (Stratagene) and pUBfRd plasmid [14], amplification of the complete Bfr gene 
(540-bp) was achieved. After purification, the 540-bp fragment of Bfr was cloned in pT7-7, 
previously cut with the appropriated restriction enzymes, and transformed in E. coli DH5a 
cells [15]. The resultant recombinant plasmid, pT7Bfr, was isolated and sequenced and 
ensured the integrity of the gene.
Cells of E. coli BL2i-Gold (DE3) (Promega) freshly transformed with pT7Bfr were 
grown overnight, at 37°C, in Luria-Bertani (LB) medium with ampicillin (100 M-g/ml) under 
aerobic conditions. This overnight culture was used (1%) to inoculate fresh LB media and 
when the cells reached a cell density of OD600nm=0.8, 400 ^M of isopropyl-thio-ß-D-
galactoside (IPTG) was added. After four hours, cells were harvested by centrifugation and 
resuspended into 10 mM Tris-HCl, pH 7.5, and broken in a French pressure cell (SLM; 
Aminco) at 9,000 psi. Analysis of the recombinant cells revealed that the overproduced DdBfr 
protein was present in inclusion bodies. Hence, inclusion bodies were collected by a low 
speed centrifugation (5,000 x g for 10 min). The pellet was dissolved in 20 mM Tris-HCl pH 
7.6 (buffer A) which contained 8 M urea, 0.5 M NaCl and 5 mM dithiotreitol (DTT) and 
stirred for 30 min, at room temperature. The insoluble material was then removed by a 
centrifugation step performed at 17,000 x g during 15 min. For reconstitution purposes, the 
supernatant that was collected by centrifugation was then dialysed in consecutive steps by 
successive additions of fresh buffer. To this end, after an initial six hours dialysis in 1 L of 
urea 8 M, the protein suspension was dialyzed eight times, in time intervals of six hours, in 
250 ml of buffer A. A final dialysis in 2 L of buffer A plus 150 mM NaCl was performed 
during twelve hours. The solution was centrifuged at 5,000 x g, 20 min and the supernatant 
concentrated in a diaflow apparatus with a membrane YM3 (Amicon). The sample was again 
centrifuged at 11,600 x g, 30 min, and then applied onto a Superdex column, S-75 (XK26/53),
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using buffer A plus 150 mM NaCl with a flow of 0.75 ml/min. After this purification step, the 
protein, identified by Western-blotting with antibodies raised against the native Dd 
haemoferritin, was found to be pure in SDS-PAGE. The recombinant Dd  Bfr was isolated in 
apo-form, i.e., with no haem or iron content.
Bacterioferritin metal loading. The protein was concentrated and diluted in 0.1 M 
MES pH 7.0 with NaCl 0.2 M buffer three times to remove TRIS-HCl from the sample. The 
water solution used to dissolve (NH4 )2Fe(SO4 ) 2  was degassed under vacuum for 30 min and 
flushed with argon for 30 min. The oxygen free iron stock solution was added to DdBfr to 
yield a final concentration of 36.5 mg/ml of 2.1 irons by protein monomer. The iron loaded 
sample was left one hour anaerobically before freezing in the sample holder (reduced DdBfr 
sample). This reduced iron loaded DdBfr sample was recycled after beam exposure and 
allowed to oxidise under air atmosphere for one hour at room temperature. The oxidised 
sample was then loaded on the sample holder and frozen for analysis (oxidised DdBfr 
sample).
A distinct sample was treated for excess iron removal with a Chelex® resin following 
iron loading. The DdBfr was loaded with 2.1 irons per protein monomer in 0.1 M MES buffer 
at pH 6.5. It was then left for oxidation for one hour before filtering slowly with Chelex® resin 
squeezed into a small syringe. The diluted iron loaded protein gathered was concentrated to
20.5 mg/ml (oxidised/Chelex®-treated DdBfr sample). Iron determination analysis by ICP 
(inductively coupled plasma) revealed that the freshly purified recombinant protein was 
metal-free and each subunit of the Chelex®-treated sample contained 1.35 iron per protein 
subunit.
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Human ferritin recombinants. The complete Human ferritin H-chain cDNA was 
introduced in pAS expression plasmid [16, 17]. The ferritin-encoding DNA region was 
amplified by PCR containing oligonucleotide primers containing base changes necessary to 
produce the required mutations: Glu-107-Asp, or Glu-27-Asp, or both. The PCR product was 
subcloned into the pGEM-T vector using the 3'-T overhangs. The resulting plasmid was 
electroporated in TG1 and sequenced. Finally the EcoRV-SphI fragment containing the 
required mutations was reinserted into expression plasmid. Production and purification of 
recombinant apoferritins are described elsewhere [16].
H u H f metal loading. The metal/protein subunit ratio was fixed to two, in order to 
saturate the ferroxidase centre and avoid metal complexation in other weaker metal-binding 
sites. For iron loaded protein, all solutions were degassed 30 min. with argon bubbling except 
the protein to avoid denaturing. Under argon atmosphere, add 5 ^l iron solution (Conc 0.381 
M, pH 2, ratio 2:1 per subunit) to 1 ml protein solution (Conc 20 mg/ml, i.e. 3.96 10-5 M of 
protein, 25 mM degassed Mes buffer, pH 6.5). Add 10 % Chelex® to the reaction tube and 
mix thoroughly, filter the mixture through a 4.5 ^m milipore unit. Allow the samples to 
oxidise under ambient atmosphere for 10 min. For zinc loaded ferritins, add 500 ^l zinc 
solution (ZnCl2 2.86 mM) to 25 ml protein solution (1.6 mg/ml 0.05 M Mes, pH 6.5). Dialyze 
against 0.05 M Mes, pH 6.5 and concentrate to 500 ^l (final protein concentration 40 mg/ml).
XAS sample preparation. The XAS sample cell consists of a polyvinylchloride body
3 2(29 x 24 x 1 mm ) with a rectangular aperture (15 x 10 mm ), forming the sample chamber 
(150 ^l). Two rectangular pieces (windows) of Kapton (polyimide film) (24 x 18 mm ) were 
glued on both sides of the cell surrounding the aperture using cyanoacrylate glue (Permacol). 
The cell was filled with the protein samples through the radial perforations, which were
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subsequently sealed with a small drop of glue. The sample was then rapidly frozen in liquid 
nitrogen to prevent leakages, and stored in a liquid-nitrogen filled Dewar vessel until the XAS 
measurement.
X AS measurements. EXAFS measurements reported here were carried out at the 
EXAFS station of the European Molecular Biology Laboratory (EMBL) Outstation at the 
Deutsche Elektronen Synchrotron (DESY) in Hamburg, Germany. The EXAFS station 
features an order sorting (Si[111] double crystal) monochromator [18], which was set at 50 % 
of peak intensity to suppress harmonics, a CANBERRA 13 element solid-state fluorescence 
detector, and an energy calibration device [19]. For fluorescence-mode measurements the 
detector was placed at an angle of 90° in the horizontal plane with respect to the radiation 
beam. The cell must be placed under an angle of 45° to the beam to allow fluorescence 
radiation to be collected onto the detector. The EXAFS scans were acquired around the Zn K- 
edge (9660 eV) between 9350 and 10359 eV, and the Fe K-edge (7120 eV) between 6900 and 
(initially) 8000, later 7600 eV. Between 15 to 25 scans per sample were taken. The XANES 
regions of the scans were compared before averaging to check for any changes in valence 
state and/or ligand geometry during exposure to X-rays; none were detected. It was found that 
some of the detectors were hit at the Fe edge by X-ray diffraction peaks (in addition to the 
fluorescence); this is presumably due to small ice crystals, although addition of a glycerol (up 
to 20 % v/v) as a cryoprotectant failed to improve the quality of the data. As a result not all 
detector contributions could be included in the summation, resulting in a lower signal-to-noise 
ratio than for the Zn EXAFS, and the Fe EXAFS had to be truncated at 475 eV (k = approx.
o _1
11 A~ ). The samples were kept at 20 K in the He exchange gas atmosphere of a closed-cycle 
cryostat during the measurements. During data collection, the storage ring DORIS III was 
operated at 4.5 GeV in the dedicated mode with ring currents between 140 and 85 mA.
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EXAFS data reduction and simulations. Data reduction was carried out with the 
EMBL Outstation data reduction package [20] including the energy calibration programs 
CALIB and ROTAX, the averaging program AVERAGE, and the background subtraction 
program REMOVE. Simulations of the calibrated, averaged, and background-subtracted 
EXAFS were carried out using default settings (von Barth ground state energy, Hedin- 
Lundqvist excited state exchange term) in the PC-compatible version (9.272) of the program 
EXCURVE [21, 22] for the ab initio calculation of phase shift and backscattering factors. As 
the starting point for our single scattering simulations for Fe and Zn EXAFS we adopted the 
models of Fig. 1C and D, respectively, that were deliberately simplified and made 
symmetrical compared to the crystal structures. The parameters of this model (occupancy, 
distance, and Debye-Waller-type factor for each shell, and the threshold energy AEF) were 
iteratively refined. The significance of each contribution to the fit was assessed from 
decreases in the values of the fit index and x (see Table S1 in Electronic Supplementary 
Material).
In simulations based on Brookhaven Protein Data Bank (pdb) files, the ligand atoms 
within 5 A of each Fe in the ferroxidase site were taken from the relevant pdb files (1nfv for 
isolated/reoxidised (A), and 1nf4 for reduced (B)) and grouped in two clusters, one around 
each of the iron ions FeA and FeB which were assumed to contribute equally to the EXAFS. 
The atoms of the amino acid side chains were grouped in units; contrary to the simulations 
based on the simplified model described above, the multiple scattering effects within such 
units were also calculated, using the default (small atom approach [23]) settings of 
EXCURVE. Before refinement, the atoms for the shells in the pdb files up to 3.4 A were also 
grouped around average values, with values for the Debye-Waller-type factors that increased 
with distance, matching the intensity of the peak in the phase-corrected Fourier transform.
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Iterative refinement of the simulation was carried out with just a few parameters: the threshold 
energy AEF: distances for a close and more remote subshell of the main shell, and for the 
shells at approximately 3.0 and 3.4 A. Attempts to include the Debye-Waller-type factors in 
these refinements led to situations where these refined to lower values for shells further away 
from the absorber and were therefore abandoned. In view of the good agreement already 
existing in the simulation based on the non-adjusted pdb file, the outer shells were not 
adjusted or refined.
Results and Discussion 
Bacterioferritin (DdBfr)
XAN ES and EXAFS. With its relatively stable ferroxidase site which has been 
crystallographically characterised in various states, DdBfr serves as an anchor point for this 
study. Contrary to the native DdBfr, which contains haem and a fully loaded di-iron 
ferroxidase centre, the recombinant DdBfr studied in this paper is obtained free of haem and 
iron. This recombinant DdBfr was reconstituted (see Materials and Methods for details) with 
Fe(II) and oxidised to give samples corresponding to the states referred to as oxidised, 
reduced, and oxidised/Chelex® treated. In the crystallographic study of native DdBfr [9], three 
different DdBfr structures were determined, viz. structures A (as isolated, anaerobically 
purified and aerobically crystallised), B (crystal reduced with dithionite), and C (solution 
reduced with dithionite, cleaned by gel filtration, and anaerobically crystallised). As shown in 
Fig. 2, the Fe XANES edge position (7121.4 eV) of bis-Fe(II) DdBfr (reduced) was 
significantly shifted (by 1.3 eV to 7222.7 eV, Figure 2) upon exposure to air (oxidized 
DdBfr), confirming the change in valence state expected for iron oxidation. Using the
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absolute energy calibration of the EMBL EXAFS station [19], the edge energies are not 
subject to accidental shifts due to i.e. variations in the angle at which the X-ray beam hits the 
monochromator crystals; they are also in line with literature data on ferritin in various 
oxidation states [24]. No reduction of the metal ion in the metalloprotein samples by X-rays 
was detectable, because neither a shift in the edge position nor a lowering of the intensity of 
the first maximum in the X-ray absorption as a function of exposure time was observed.
- - - FIGURE 2 - - -
It was of course of interest to see if the difference in edge position and hence in 
valence state was in any way reflected in the bond distances and occupancies to be derived 
from the EXAFS. The EXAFS is an average of contributions of the Fe ions in the left and 
right ferroxidase sites, and even though most Fe-O/N distances are probably similar, it is only 
the Fe-Fe distance that is the same for both. In our initial simulations we adopted a model 
(Fig. 1C) that was deliberately simplified (including substitution of the single imidazole N 
ligand donor atom per Fe, which is not resolved from the other first shell ligands, by another 
O, which is virtually indistinguishable in EXAFS) and made symmetrical compared to the 
crystal structure (Fig. 1B); this model has a number of independent parameters to be refined 
iteratively that is as low as possible, but it does account for all the resolved shells in such a 
way that the results can still be related to a molecular model for the ferroxidase site. One 
would normally not expect to detect the non-coordinating oxygen in a carboxylate group; in 
the model of Fig. 1C this is more likely because of its rigidity (a ring of 2 carboxylate and 2 
metal ions holding eachother in place, leading to more correlated thermal motion, and hence 
lower values for the Debye-Waller-type factors, for all the absorber-backscatterer pairs 
involved) and geometry (the Fe-O-C and Fe-O-O angles are approx. 140 and 125o,
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respectively, which makes enhancement of the contribution of the remote atom by multiple 
scattering effects more likely). It has to be noted that simulations based on models such as in 
Fig. 1C, where atoms are not grouped in a multiple scattering unit, and only single scattering 
contributions are considered, might lead to relatively large errors in the outer shell 
occupancies and even distances due to the neglect of these effects. Taking this approach, 
simulations (Figure 3, Table 1) using EXCURVE [21, 22] show that the average Fe-O/N 
ligand distance changes from 2.02 A for the reduced to 1.99 A for the oxidised sample, in line 
with the shorter ionic radius expected for the Fe(III) ion compared to the Fe(II). The Fe-Fe 
distances for oxidised and reduced protein obtained from these refined simulations are much 
more similar than those in the crystal structure, viz. EXAFS 3.810 A for reduced vs. 3.882 A 
for oxidised (crystallography: structure A - 3.99 A vs. structure B - 3.71 A). It should be 
noted, however, that the effect of inclusion of the Fe-Fe contribution on the fit index is small 
(see Table S1, Electronic Supplementary Material), and that satisfactory refined simulations 
with fit indices only marginally higher than those for the simulations that are shown here can 
be obtained when the Fe and remote O shells are interchanged, resulting in Fe-Fe distances of 
approx. 3.4 A, which is significantly shorter than the crystallographic values. Such a model 
for the simulations of the ferroxidase EXAFS would be more difficult to link with any of the 
models B and C in Figure 1, however. There are examples of high-resolution small molecule 
crystal structures that feature Fe-Fe distances similar to the ones found in the DdBfr crystal 
structure and in our final EXAFS simulations, such as that of (^2-acetato)-(^2-m- 
xylylenediamine bis(Kemp's triacid) imido)-bis(N-methylimidazol-3-yl)-tris(methanol)-di- 
iron(ii) tetrafluoroborate (CSD code REKFUI, Fe-Fe 3.827 A) [25].
For the oxidised/Chelex®-treated DdBfr sample the situation is different: an even 
shorter average Fe-ligand distance (1.97 A, compatible with five- to six-coordination
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according to bond valence sum analysis, as discussed below) is observed, along with an 
unambiguous Fe-Fe contribution (see Table S1, Electronic Supplementary Material), with 
increased (1.5) occupancy, at 3.39 A. The crystal structure of the wild type DdBfr that was 
aerobically crystallised (structure C, the cycled-oxidised, or reduced-then oxidised structure) 
shows that only one of the Fe sites in the ferroxidase site, the FeB (right) site, is occupied, in 
which case no Fe-Fe distance is expected to be detectable by EXAFS. The distance of 3.4 A is 
more characteristic of mineralization of Fe together with O in the ferritin core, cf. the results 
for fully loaded horse spleen ferritin [12] (6 O at 1.96 A, 1.1 Fe at 3.43 A), and the spectra 
resemble those of [26] which are simulated with 5 O at 1.95 A and two iron contributions (3.7 
at 3.00, and 2.0 at 3.53 A). A distance of 3.38 A for a Fe-Fe contribution, along with 5-6 N/O 
at 1.96 A, has also been observed for horse spleen apoferritin reconstituted with 2 
Fe(III)/subunit [11], and most likely represents a protein-bound polynuclear Fe-O cluster 
there. The EXAFS result for oxidised/Chelex®-treated DdBfr, including the increased 
occupancies of the remote O and Fe shells, points to the presence of biomineralized Fe in the 
sample. It would imply that following oxidation part of the iron leaks from the ferroxidase 
site, leaving only the FeB site occupied, and forms Fe-O clusters so small and so irregular that 
they escaped detection in the crystallographic study of the wild type [9]. Clearly, of the three 
states of DdBfr studied here, the oxidised/Chelex®-treated sample is least interesting in terms 
of direct comparison of EXAFS and crystallography results, but the EXAFS does give an 
indication of where the Fe supposed to be present in the FeA site in structure C of the 
crystallographic study may have gone.
- - - FIGURE 3, TABLE 1 - - -
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Comparison with Crystal Structure. The crystal structures of the as-isolated (A) and 
reduced (B) wild-type DdBfr [9] show little symmetry in the Fe coordination (Table 2), and 
no indication of a difference in ionic radius between the Fe(II) and Fe(III) states. It is of 
interest to compare the EXAFS results for the oxidised and reduced DdBfr samples with what 
are most likely to be their crystallographic analogues, the as-isolated structure A and the 
reduced structure B, respectively. The average ligand distance determined by EXAFS (Table
1) for oxidised DdBfr is shorter by 0.25 A, that for reduced DdBfr by 0.21 A. The difference 
in the average ligand distances is larger than can be explained by the accepted errors for either 
technique (± 0.02 A for EXAFS, ± 0.14 A for crystallography). From the crystallographic data 
for the DdBfr ferroxidase site the static disorder astatic can be calculated on the basis of the 
deviations of the Fe-ligand distances from the average value (see Table 2) giving values of 
0.15 A for the as-isolated form A, and 0.14 A for the reduced form B. The Debye-Waller-type 
factor a  (or EXAFS Debye-Waller factor, refined as 2a2 in EXCURVE simulations) is the 
sum of contributions representing static (astatic) and thermal (athermal) disorder and can 
therefore be considered to indicate the maximum possible static disorder or variance, 
assuming that there is no thermal disorder at 20 K. The Debye-Waller-type factors refine to 
0.09 and 0.10 A for oxidised and reduced, respectively. These values are significantly lower 
than the crystallographically derived astatic, which is a strong indication that the ferroxidase 
site is probably more symmetrical, with less spread in the Fe-ligand distances, than the 
crystallographic model suggests. The case is comparable, albeit more complicated, to that of 
an early biological EXAFS study on rubredoxin, where the possibility that rubredoxin had 
both relatively long and short Fe-S distances was rejected [27, 28].
- - - TABLE 2 - - -
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The longer average distance for the crystal structure is caused in part by the inclusion 
of both oxygens of bidentate Glu residues, and it is possible that the more remote oxygen does 
not contribute to the EXAFS. In the initial EXAFS simulations, the occupancy of the main 
shell (coordination number) refines to values around 5, but because of their strong correlation 
with the Debye-Waller-type factor the error of coordination numbers can be as high as 30 %; 
a refined value of 5 could therefore still be 4 or 6 in reality. Bond valence sum analysis 
(BVSA, [29]) offers an approach to use the accurate determination of bond lengths to get 
information about the coordination numbers. For the application to ferritin, we have neglected 
the contribution of the single histidine N per iron site and substituted it by another O, keeping 
in mind that a typical Fe-N distance is longer than a Fe-O distance by 0.07 A for Fe(II) and 
0.1 A for Fe(III). For the Fe(II) (reduced) protein the average Fe(II)-O ligand distance of 2.02 
A found by EXAFS is in between those characteristic of four- (1.99 A) and five-coordination 
(2.07 A). This could point to the presence of one four- and one five-coordinated site, which 
would imply that the longest Fe-ligand contacts found in the crystallographic structure B 
(reduced), viz. the water oxygen in the left (FeA) site and the remote E99-carboxylate oxygen 
in the right (FeB) site, both at 2.46 A, do not contribute to the EXAFS. For the oxidised 
protein, the average Fe(III)-O ligand distance of 1.99 A found by EXAFS is in between those 
characteristic of five- (1.95 A) and six-coordination (2.02 A). This means that all the ligands 
found in the oxidised crystallographic structure A (as-isolated) probably contribute to the 
EXAFS, even the remote E99 carboxylate oxygen and H135 nitrogen found at 2.52 and 2.57 
A, respectively. There is also the possibility that coordination positions that are apparently 
empty in the crystal structure are taken up by small ligands, such as water, molecular oxygen, 
or peroxide, at a relatively short distance, that have gone undetected in the crystal structure. 
For the as-isolated (oxidised) DdBfr (A) this should certainly be considered, as there is some 
electron density on the site of the Fe(III) corresponding to the top in Fig. 1B, which can be
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fitted with water and/or (per)oxo-bridges, but not unequivocally, presumably because of the 
presence of a mixture of states. Recently [30] as-isolated DdBfr has been reinvestigated by 
crystallography under circumstances where radiation damage is minimised, and an end-on 
peroxo ligand to FeB could be tentatively identified. It is worth noting that such a non-protein 
ligand would be compatible with the occupancy determined for oxidised DdBfr by EXAFS, as 
well as with further considerations on the coordination number based on BVSA.
We find that the EXAFS ligand distances are in good agreement with what is expected 
for five- or six-coordination according to BVSA [29], especially for the Fe(III) valence state. 
Moreover, the crystallographic distances are much higher than those considered typical for Fe 
on the basis of a survey of high-resolution crystal structures [31], which are 2.01 A for Fe- 
O(carboxylate) and 2.08 A for Fe-N(histidine). These conclusions inspire confidence in the 
EXAFS results. We decided to use the EXAFS simulation program EXCURVE to simulate 
EXAFS on the basis of crystallographic coordinates as available from the Brookhaven Protein 
Data Base, a so-called pdb file, in order to see where the main deviations were and by which 
adjustments better agreement between EXAFS and crystallography results might be reached. 
In these simulations, the ligand atoms within 5 A of each Fe in the ferroxidase site were taken 
from the relevant .pdb files (1nfv for as-isolated (A) and 1nf4 for reduced (B), applied to the 
oxidised and reduced DdBfr EXAFS results, respectively) and grouped in two clusters, one 
around each of the iron ions FeA and FeB which were assumed to contribute equally to the 
EXAFS. The atoms of the amino acid side chains were grouped in units; contrary to the 
simulations based on the simplified model described above, multiple scattering effects within 
such units were also calculated.
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As expected after our simulations based on the symmetrised model in Fig. 1C, the 
initial agreement between the experimental EXAFS and the simulation based on the 
coordinates from the Protein Data Base was very poor (see trace (i) in Figure 4 for reduced 
DdBfr, and Figure S1 in the Supplementary Material). Not only were the Fe-ligand distances 
overestimated, but in addition the static disorder or variance in the Fe-ligand distances was 
larger than expected. On the other hand, the agreement between theory and experiment for the 
outer shells was already very good, considering that all Debye-Waller-type factors had been 
arbitrarily set to 0.010 A , and a value for the threshold energy AEF had been chosen, not 
refined. The agreement for the main shells was improved considerably by setting the average 
Fe-ligand distance of this shell to the value arrived at in the preliminary simulations presented 
in Figure 3 and Table 1, and adjusting the Debye-Waller-type factor for this shell by hand. 
Obviously this still resulted in poor agreement with the crystallographic distances, as 
discussed above (average crystallographic distance underestimated by 0.21-0.25 A). It was
noted that the values for the Debye-Waller-type factors used in the simulation for the first
2 2  shell (0.017 A for oxidized, 0.022 A for reduced) were much higher than the value of 0.010
A that was arbitrarily chosen for the outer shells and found to give good agreement there.
This is an artificial situation as the values for the Debye-Waller-type values are supposed to
go up with the distance to the central absorber, not down. It was therefore decided to split the
main shell into two subshells with lower values for the Debye-Waller-type factors. Detailed
inspection of the distances in Table 2 revealed that the oxygens of the bridging glutamate
ligands were found at relatively short distances (2.02-2.16 A, compared to the average of 2.23
A) from the iron ions in the crystallographic study. These (2 per Fe) were selected to be at a
relatively short distances (1.96 A for oxidised, 1.99 A for reduced), whereas the others were
put at larger distances (2.02 A for oxidised, 2.05 A for reduced), in such a way that the
resulting average ligand distance was close to that obtained from the EXAFS simulations
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based on a simplified model (Table 1, see Materials and Methods for more details). These 
adjustments resulted in a significant improvement of the agreement between simulated and 
experimental EXAFS as can be seen from traces (ii) in Figure 4 (and Figure S1 in the 
Supplementary Material). The agreement could be even further improved by iterative 
refinement of the AEF and distance parameters (not the Debye-Waller-type factors) resulting 
in the satisfactory fits of traces (iii) in Figure 4 (and Figure S1). It can be seen from a 
comparison of the EXAFS parameters obtained in this way, given in italic in Table 2, that the 
distances to the bridging glutamate oxygens need to be shortened by only approx. 0.1 A, and 
to the other atoms, except the very remote ones, by only 0.15 A to get agreement. This is a far 
less drastic shift than the 0.2-0.25 A difference in the average values and one that is almost 
within the accepted error for the crystallographic distances. The adjusted distances resulting 
from the EXAFS are given together with the crystallographic values in italic in Table 2, and a 
graphical representation of the adjustment for the reduced DdBfr, based on .pdb file 1nf4 [9], 
is given in Figure 5. It would have been of interest to investigate whether the crystallographic 
data of the DdBfr crystal structure are better fitted by a model based on the metal-ligand 
distances obtained by EXAFS. A practical problem is the large number of protein monomers 
(16) comprised in the asymmetric unit, which means that the coordinates of the ligands of 32 
Fe atoms would have to be edited before the structure could be refined again. Another 
problem is that at the current resolution (around 2 A for the DdBfr structures [9]), the 
apparent electron density around the metal ions is disturbed by termination effects in the 
Fourier transformation (Fourier ripple effects, see [32] for an early discussion of the case of a 
dinuclear Fe protein). There are examples where metalloprotein structures have been 
improved by EXAFS studies but they are usually based on new crystallographic data with a 
higher resolution (see [33] for examples).
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- FIGURE 4, 5 -
The application of the procedure described above for the reduced and oxidised DdBfr 
to the sample corresponding to the Chelex®-treated DdBfr using coordinates of the structure 
from the crystallographic study [9] that most corresponds to it, the aerobically crystallised, 
cycled-oxidised (reduced, then oxidised) DdBfr (structure C, .pdb file 1nf6), was expected to 
be problematic. The simulations based on the simplified model (Figure 3, Table 1) had 
detected the presence of a strong Fe-Fe contribution at 3.4 A, which was not expected on the 
basis of the crystal structure [9], where only FeB is occupied. Indeed it was found necessary to 
add an Fe contribution at 3.4 A in the EXAFS simulation based on .pdb file 1nf6. As 
discussed above, this Fe-Fe distance is reminiscent of that found in polynuclear Fe-O clusters 
such as found in the core of ferritin loaded with Fe; the simulation result confirms that at least 
in the EXAFS sample the Fe is not only present in the ferroxidase site, but also mainly in such 
(bio)minerals. The fact that the EXAFS spectrum at best partially represents the FeB site in 
.pdb file 1nf6 makes it difficult to investigate the role of one or perhaps even two water 
ligands to this iron.
Human Ferritin H chain (rHuHF)
Zn-loaded rH uH F variants. A number of Human ferritin H-chain mutants have been 
studied by crystallography [8] using Zn(II) ions as redox-invariant analogues of Fe(II), and 
this approach to study ferritin with other metal ions such as Mn has also been taken for X-ray 
absorption spectroscopic studies [34]. The Zn K edge spectra of the rHuHF mutants incubated 
with 2 molar eq. of Zn(II) differs mainly in the intensity of the so-called white line, the first 
maximum in the X-ray absorption spectrum at 9670 eV (white line, Fig. 6). For a coherent
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coordination sphere an increase in intensity in the white line can be attributed to a higher 
coordination number [35]. Comparing the white line intensities with those of model 
compounds of known coordination (Figure 6) [36, 37], it can be concluded that rHuHF- 
E107D and rHuHF-E107/E27D mutants, which are indistinguishable, are close to the four- 
coordinated model compounds. The intensities of the white lines of the wild type (K86Q) and 
rHuHF-E27D mutant, which are also indistinguishable, are between those characteristic for 
four- and five-coordination, possibly indicating the presence of one four- and one five- 
coordinate site.
- - - FIGURE 6 - - -
By analogy to the model for the bacterioferritin ferroxidase site (see above, Fig. 1C), a 
symmetrised model was constructed for the dinuclear Zn-loaded HuHF ferroxidase site (Fig. 
1D). In one aspect this model is a larger simplification compared to the structure known to 
exist in the protein crystal structure, viz. HuHF contains only one glutamate bridge (Fig. 1A) 
whereas bacterioferritin (Fig. 1B) and the model (Fig. 1D) contain two. On the other hand, the 
simplification of the substitution of the imidazole by another oxygen is more justified, since 
bacterioferritin contains 2 His ligands (1 His ligand/metal), whereas the HuHF has only one 
(to FeA). Simulations of the Zn-rHuHF EXAFS spectra (Figure 7, Table 3) reveal strong 
similarities. The spectra show Zn-O (probably carboxylate O) contributions around 2 A, Zn-C 
(again carboxylate) at 3 A, and Zn-Zn distances at 4 A. The observed Zn-Zn distances are a 
little shorter than the expected distances of remote imidazole ring atoms (4.2 A). However, 
attempts to simulate the spectrum with rigid imidazoles failed because a remote ring atom at 
4.0 A would imply a ligand donor atom at 1.8 A; this is not compatible with the data and 
moreover chemically unrealistic. It must be concluded that the single imidazole per metal
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atom in the HuHF ferroxidase site does not contribute significantly to the EXAFS. This is 
somewhat unexpected, but it must be noted that examples where even three imidazole ligands 
to an iron atom do not give a detectable outer shell contribution to the EXAFS have been 
reported [38]. The intensity of those EXAFS features has also been found to depend on the 
orientation of the imidazole ligand with respect to the metal-donor atom bond [36].
- - - FIGURE 7, TABLE 3 - - -
The first-shell distances (2.00-2.01 A) are in good agreement with those expected for a 
four-coordinate Zn-O complex according to BVSA [29], viz. 2.03 A, and with the Zn- 
O(carboxylate) distance of 2.04 A found in the survey of high-resolution crystal structures 
[31], especially when the possible presence of one shorter Zn-N(His) (1.96 in BVSA, 2.00 A 
in the survey) is taken into account. The lack of significant differences is surprising in view of 
the effects that might have been expected on the basis of the mutants of the glutamate ligands 
on either site of the dinuclear site. However, it should be noted that the geometries, in 
particular the Zn-Zn distances, of the Zn-occupied ferroxidase sites as determined in the 
various mutants by crystallography [8] are also rather similar (3.32 A for “wild type” K86Q, 
3.44 A for E27D, and 3.38 A for E107D) apart from rHuHF- E27D/E107D, which did not 
have its ferroxidase site occupied with two Zn ions in the crystal structure. The Zn-Zn 
distances determined by crystallography [8] are much shorter than those determined by 
EXAFS in the present study. Additional EXAFS simulations where the Zn and O shells at 4.0 
and 3.8 A are interchanged have almost as good fit indices as the ones presented in Table 3 
and Figure 7, but the Zn-Zn distance from EXAFS is under no circumstances shorter than 3.8 
A. We note that there are examples of crystal structures of synthetic dinuclear Zn complexes 
that feature Zn-Zn distances in this range, such as bis(^2 -acetato)-bis(ethyl 2-cyano-3-[(2,6-di-
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isopropylphenyl)amino]-N-(2,6-diethylphenyl)prop-2-enimidoato)-di-zinc (CSD code 
DEQTEZ, Zn-Zn 3.963 A) [39] and bis((^2-acetato-O’O')-(2-(2-(pyrrolidyl)ethyl)-1’3’4’5- 
tetramethyl-cyclopentadienyl))-di-zinc (CSD code XOJSEU, Zn-Zn 3.823 A) [40]. We 
conclude that the most important factor that determines the Zn-Zn distance is the bridging 
glutamate (E62), and that moving the carboxylates of E27 and/or E107 has little effect. 
Crystallography shows that the Zn sites are three- or four-coordinated, with Zn-ligand 
distances for “wild-type” (K86Q, average 2.16 A) and rHuHF-E27D (2.10 A) that are longer 
than those determined by EXAFS, although not as much longer as those in the DdBfr 
structure. For “wild type” and this mutant the agreement between EXAFS and crystal 
structure rHuHF is quite good if one moves each Zn ion 0.10-0.15 A towards the glutamate 
ligands at either end of the ferroxidase site, elongating the Zn-Zn distance correspondingly. 
For rHuHF-E107D the distance of the D107 to the Zn ion to the right is much longer (3.2 A) 
than the EXAFS distances, and probably small (water) ligands not observed in the crystal 
structure complete the coordination sphere for this ion. For rHuHF-E27D/E107D there is no 
agreement between EXAFS and crystallography, and one must conclude that the soaking of 
the crystals with Zn and the preparation of the Zn derivative in solution by adding two 
equivalents of the metal have resulted in samples with different metal loading. A more 
detailed comparison of the EXAFS and crystallographic results such as discussed for DdBfr is 
hampered by the problem that in the rHuHF crystal structures, the Zn(II) ions have never 
more than three protein ligands (in one case -  ZnB in rHuHF-E107D -  only one) and that only 
few of the non-protein ligands have been localised, whereas the EXAFS clearly indicates 
coordination numbers of at least four.
Fe-loaded rH uH F variants. Samples were incubated with iron under transiently 
anaerobic conditions under an argon atmosphere to favour the homogeneity of iron
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distribution; by maintaining iron in the Fe(II) form, we anticipated that, as in the case of 
native DdBfr [9] we would restrict iron uptake to only two iron atoms into each ferroxidase 
centre. Controlled oxidation was then allowed to proceed before the sample was flash-frozen 
and X-ray absorption data were collected on the frozen solution. In this way we expected to 
be able to monitor any oxidation of the iron ions, as well as their possible migration from the 
ferroxidase centre to the nucleation site.
The edge spectra in Figure 2 show that the edge position of rHuHF-E27D/E107D 
mutant sample is close (7121.8 eV) to that of the reduced DdBfr (7121.4 eV) implying that it 
has retained significant Fe(II) character (cf. [24]. The “wild type” rHuHF (K86Q) edge is at
7122.5 eV and close to that of the oxidised DdBfr, implying a significant degree of oxidation 
(and perhaps mineralization). The bis-Fe complexes of the mutants in which only a single 
glutamate was changed to an aspartate, rHuHF-E27D and rHuHF-E107D, were found at 
intermediate energies. For rHuHF and rHuHF-E107D, the fast oxidation and its total absence, 
respectively, are in line with their observed relative reactivities in the accumulation of Fe(III) 
ions upon addition of Fe(II) to the apoprotein under aerobic conditions [8]. Based on these 
measurements, rHuHF-E27D was expected to be even more easily oxidized than the wild 
type, whereas rHuHF-E27D/E107D showed no activity at all.
Simulations of the EXAFS spectra on the basis of the symmetrized model (Fig. 1C) 
that was also applied to the DdBfr data were carried out to probe the environment up to 3-4 A 
from the absorbing Fe atom for the presence of a high-Z atom (Fe, see Fig. 8). Some of the Fe 
rHuHF EXAFS spectra, viz. those for rHuHF-E27D/E107D and rHuHF-E107D, have lower 
signal-to-noise ratio than the others, because fewer detector contributions could be included 
(see Materials and Methods); they are nevertheless included here to complement the Zn edge
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and EXAFS and Fe edge results. The results of the best simulations are given in Table 4. 
Interestingly, none of the observed Fe-O distances is at 2.0 A or higher such as observed for 
the Zn analogues or the Fe in reduced DdBfr; all Fe-O distances fall in the range 1.97-1.99 A, 
even rHuHF-E107D which appears to have both its Fe as Fe(II) judging from the edge (Fig.
2). For this last mutant, the BVSA indicates that the coordination number most likely 
correlated with Fe(II)-O distances of 1.99 A is four; this means that in addition to the 
expected protein ligands (E62 for both Fe, E27 and H65 to the left, E107 to the right) there is 
probably at least one small non-protein ligand, possibly the water oxygen already indicated 
for FeA (Fig. 1A). For the others it is in between five and six, assuming considerable or 
complete conversion to Fe(III).
For rHuHF-E27D/E107D and rHuHF-E107D very weak Fe-Fe contributions at 
respectively 3.96 and 3.12 A were detected, which have to be considered insignificant in view 
of the noise in the data; the most important conclusion from these simulations is that there are 
no strong Fe-Fe contributions in the 3.4 A range. Such contributions were very strongly 
present in the data for rHuHF and the E27D mutant. We note that these distances are much 
shorter than those observed for DdBfr and Zn-loaded rHuHF but in the same range as those 
found with crystallography for Zn-HuHf; however, in the Zn EXAFS such short distances 
were not detected. Imidazole contributions were not required to simulate any of the rHuHF Fe 
EXAFS, in line with the observations for the Zn HuHF analogues where there is also only 0.5 
imidazole/metal expected. It rather looks like the presence of relatively short Fe-Fe distances 
for the wild type and the E27D mutant points to the presence of a significant amount of 
mineralized Fe in those samples. This is also consistent with the relatively high occupancies 
of the Fe-O shells and the Fe-O distances which are a little bit too short to be all Fe- 
O(carboxylate) distances when compared to the distance value of 2.01 A given in the
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metalloprotein crystal structure survey [31]. The observation of polynuclear Fe-O cluster 
formation upon addition of Fe(II) ions to apoferritin is consistent with literature results [11, 
41].
- - - FIGURE 8, TABLE 4 - - -
Concluding Remarks
The X-ray absorption near edge region of the spectrum (XANES) allows the oxidation 
state of the Fe ions to be assessed, and reflects the oxidation state of the DdBfr as well as the 
different reactivities of rHuHF mutants. In the case of rHuHF reconsitituted with Zn, 
information on coordination number and geometry is derived from the XANES. Simulations 
of the Extended X-ray absorption fine structure (EXAFS) have yielded accurate geometric 
information that represents an important refinement of the crystal structure, adjusting most 
metal-ligand bonds to shorter distances and allowing differences between the Fe(II) and 
Fe(III) states that are consistent with the ionic radii to be established. Moreover, the results 
give a clue about the state of Fe in the aerobically crystallised/cycled-oxidised form of the 
DdBfr, where the crystal structure (C) shows the dinuclear site to be only half-occupied; the 
EXAFS of the analogous oxidised/Chelex®-treated sample provides evidence that the other 
iron is used in a mineralization process. In the case of rHuHF the complexes with the redox- 
inert Zn reveal a surprising similarity among the variants. This is in line with the crystal 
structures of 3 mutants, although the metal-ligand and metal-metal distances found with 
EXAFS are shorter and longer, respectively. The Zn results indicate that the metal-metal 
distances are not much affected by the mutations of E27 and/or E107 to aspartates. This 
means that the observed differences in ferroxidase reactivity must be explained by the effect
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of the mutations on other parameters not assessed in this EXAFS study, such as the affinity of 
each of the sites A and B for the metal ion, and the subsequent reactivity towards dioxygen. In 
spite of the apparent rigidity of the dinuclear site the rHuHF complexes show a variation in 
reactivity that is reflected in the Fe oxidation states and coordination geometries. As in the 
case of the oxidised DdBfr (C), considerable mineralization has occurred for the wild type and 
the most reactive mutant (rHuHF-E27D), resulting in EXAFS-detectable Fe-Fe distances of 
3.4 A.
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Figure 1. Schematic representation of ferroxidase site.
(a) Human H ferritin, adapted from ref. [8] (E61 is conserved and was implied in metal 
coordination in early crystallographic studies [5, 6]). (b) Oxidised Desulfovibrio desulfuricans 
bacterioferritin, adapted from ref. [9] structure A (E99 is asymmetric bidentate in the reduced 
structure B, and monodentate in the aerobically crystallised/cycled-oxidised structure C). (c) 
and (d), starting models for the EXAFS simulations of Fe- and Zn-loaded ferritins, 
respectively, with the numbers in red bold indicating the distance to the red bold metal atom.
Figure 2. Fe K Edge of Fe-loaded ferritins, from low to high energy: blue, rHuHf-E107D; 
green, reduced DdBfr; orange, rHuHf-E27D/E107D; brown, rHuHf-E27D; grey, “wild type” 
rHuHf (K86Q); turquoise, Chelex®-treated DdBfr; red, oxidised DdBfr.
Figure 3. k -weighted Fe K EXAFS (left panel) and corresponding phase-corrected Fourier 
transform (right) of Desulfovibrio desulfuricans bacterioferritin (DdBfr). Coloured traces, 
experimental: turquoise, Chelex®-treated; red, oxidised; green, reduced; black thin solid 
traces, corresponding simulations with the parameters listed in Table 1.
Figure 4. k -weighted EXAFS (left panels) and corresponding phase-corrected Fourier 
transform (right) of reduced Desulfovibrio desulfuricans bacterioferritin (DdBfr). (i) EXAFS 
simulation on the basis of the .pdb file related to the crystal structure of reduced wild type 
DdBfr [9], 1nf4 (distances in Table 2); (ii) major shells adjusted to the average EXAFS value 
found in the initial simulation given in trace (iv), Figure 3 and Table 1; (iii) simulation 
obtained by iterative refinement of the AEF and distance values, starting from the adjustment 
in (ii), resulting in the distances given in italic in Table 2; (iv) simulation based on the 
simplified model in Fig. 1c, refining to the parameters in Table 1.
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Figure 5. Ferroxidase site in reduced DdBfr with Fe-ligand distances in A: A) as determined 
by crystallography [9], B) adjusted to give agreement with the EXAFS. Colour code: grey, 
carbon, red, oxygen; blue, nitrogen; orange, Fe; hydrogens are omitted for clarity. Green and 
blue distance values refer to FeA (left Fe ion) and FeB (right), respectively.
Figure 6. Zn K edge of Zn-loaded rHuHF (bold: blue rHuHF-E107D, colliding with orange: 
rHuHF-E27D/E107D; violet: rHuHF-E27D, colliding with green: “wild type” rHuHF 
(K86Q)) and Zn complexes (thin lines: light green, tetrakis(imidazole)Zn(II) diperchlorate 
(Zn(Im)4 , tetrahedral 4-c.); orange, bis(acetato)bis(imidazole)Zn(II) (ZnIm2Ac2 , near 
tetrahedral 4-c.); red, zinc oxide (ZnO, tetrahedral 4-c.); dark green, bis(L-histidino)Zn(II) 
dehydrate (Zn(His)2 , tetrahedral 4-c.); turquoise, bis[(imidazol-2-yl-thiophen-2- 
yl)methanol]zinc(II) sulphate hydrate (Zn(ImThOH)2 , 5-c.); pink, triaquabis(N - 
benzoylglycinato)zinc(II) dihydrate (Zn(H2O^(BzGly)2 , 5-c.); brown, 
tetraaquabis(hydrogenmaleato)zinc(II) (Zn(mal)2 , octahedral 6-c.); see [36, 37] for details of 
models.
Figure 7. k -weighted Zn K EXAFS (left panel) and corresponding phase-corrected Fourier 
transform (right) of rHuHF. Coloured traces, experimental: green, “wild type” rHuHF 
(K86Q); violet, rHuHF-E27D; orange, rHuHF-E27D/E 107D; blue, rHuHF-E107D; black thin 
solid traces, corresponding simulations with the parameters listed in Table 3.
Figure 8. k -weighted Fe K EXAFS (left panel) and corresponding phase-corrected Fourier 
transform (right) of rHuHf. Coloured traces, experimental: green, “wild type” rHuHF (K86Q);
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1 violet, rHuHF-E27D; orange, rHuHF-E27D/E107D; blue, rHuHF-E107D; black thin solid
2 traces, corresponding simulations with the parameters listed in Table 4.
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1 Tables
2 Table 1. Refined parameters for the Fe K EXAFS simulations shown in Fig. 3 a
Oxidised Reduced Chelex®-treated
Shell: O 5.2 @ 1.99 (.017) 4.9 @ 2.02 (.022) 5.2 @ 1.97 (.018)
a  1st sh. 0.09 A 0.10 A 0.09 A
Shell: C 2.0 @ 3.02 (.003) 2.1 @ 3.01 (.003) 2.7 @ 3.05 (.007)
Shell: O 2.6 @ 3.39 (.004) 2.2 @ 3.39 (.013) 7.9 @ 3.49 (.030)
Shell: Fe 1.1 @ 3.88 (.030) 0.6 @ 3.81 (.025) 1.5 @ 3.40 (.020)
AEF -4.1144 -3.0322 -3.7810
eV range 2.5 - 475 2.5 -  475 3 -  475
Fit index 0.1259*10-3 0.1066*10-3 0.1133*10-3
Edge b 7122.7 7121.4 7122.4
a 0 2 0 23 ) Distances in A; Debye-Waller-type factors as 2a  in parentheses in A
4 b) Energy position at half height (eV)
5
6
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1 Table 2. Comparison of Fe-ligand distances (in Â) determined by crystallography (normal,
2 adapted from [9], see Fig. 1B for schematic representation) and adjusted/refined by EXAFS
3 (italic).
pdb
code
1nfv 
(A) as isolated a)
1nf4 
(B) reduced b)
1nf6
(C) cycled-oxidised c)
FeA FeB FeA FeB FeA FeB
Glu 23 2.24, 2.24 
2.08, 2.08
2.26, 2.26 
2.09, 2.09
Glu 56 2.12, 1.94 2.16, 1.94 2.09, 1.94 2.14, 1.94 2.97, 2.06
2.97, 1.93
Glu 99 2.11, 2.52 
2.08, 2.08
2.19, 2.46 
2.09, 2.09
3.07, 2.24
3.07, 2.01
His 135 - 2.57, 2.08 - 2.27, 2.09 - 2.14, 2.01
Glu 132 2.04, 1.94 2.02, 1.94 2.05, 1.94 2.04, 1.94 3.16, 1.93 
3.24, 1.93
His 59 2.23, 2.08 - 2.23, 2.09 - - -
OW - - 2.46, 2.09 - - 3.63, 3.49
Fe-Fe 3.71, 3.41 = 3.99, 4.04 = - -
Aver/ 10.87/5 = 11.48/5 = 13.35/6 = 11.1/5 = 15.43/7 = 8.37/4 =
Site 2.174
2.02
2.296
2.02
2.225
2.04
2.220
2.03
2.204 2.093 
(4) 1.97
a 0.06 0.20 0.13 0.09 (7) 0.57 (4) 0.11
Aver./c 22.35/10 
= 2.235 
2.02
0.15 24.45/11 
= 2.223 
2.04
0.14
4
5 a) EXAFS parameters for oxidised DdBfr (cf. Fig. S1A, trace iii)
6 b) EXAFS parameters for reduced DdBfr, cf. Fig. 4 (and Fig. S1B), trace iii, and Fig. 5B
7 c) EXAFS parameters for Chelex®-treated DdBfr (cf. Fig. S1C, trace iii)
32
1 Table 3. Refined parameters for the Zn K EXAFS simulations shown in Fig. 7 a
rHuHF (K86Q) rHuHF-
E27D
rHuHF- 
E27D/ E107D
rHuHF-
E107D
Shell: O 4.9 @ 2.00 (.019) 4.8 @ 2.00 (.018) 4.7 @ 2.00 (.016) 4.9 @ 2.01 (.020)
Shell: C 0.5 @ 3.01 (.004) 0.6 @ 2.99 (.001) 0.8 @ 3.03 (.006) 0.6 @ 2.98 (.001)
Shell: O 5.3 @ 3.79 (.025) 4.9 @ 3.78 (.022) 5.4 @ 3.82 (.023) 3.7 @ 3.82 (.017)
Shell: Zn 0.8 @ 3.98 (.016) 1.0 @ 3.97 (.013) 2.3 @ 4.00 (.030) 1.3 @ 3.99 (.018)
AEF -10.3233 -10.3910 -11.6095 -11.9367
eV range 25-722 25-722 25-722 25-718
Fit index 0.1059*10-3 0.0901*10-3 0.2297*10-3 0.1588*10-3
a 0 2 0 22 ) Distances in A; Debye-Waller-type factors as 2 a  in parentheses in A
3
4 Table 4. Refined parameters for the Fe K EXAFS simulations shown in Fig. 8 a
rHuHF (K86Q) rHuHF-
E27D
rHuHF- 
E27D/ E107D
rHuHF-
E107D
Shell: O 5.1 @ 1.98 (.015) 4.7 @ 1.97 (.016) 5.1 @ 1.98 (.021) 4.7 @ 1.99 (.010)
Shell: C 1.2 @ 3.03 (.003) 1.7 @ 3.11 (.001) 2.7 @ 3.05 (.005) 2.7 @ 2.93 (.004)
Shell: O 4.4 @ 3.49 (.003) 4.8 @ 3.55(.003) 6.3 @ 3.46 (.030) 3.3 @ 3.32 (.003)
Shell: Fe 1.7 @ 3.38 (.004) 2.1 @ 3.40 (.003) 1.1 @ 3.96 (.023) 1.1 @ 3.12 (.003)
AEF -3.9150 -3.3515 -3.1847 -2.3904
eV range 2.5 -  475 2.5 -  475 3 - 472 2.5 -  475
Fit index 0.1620*10-3 0.2310*10-3 0.4782*10-3 0.6311*10-3
Edge b 7122.5 7121.8 7121.8 7121.0
a 0 2 0 25 ) Distances in A; Debye-Waller-type factors as 2 a  in parentheses in A
6 b) Energy position at half height (eV)
33
12
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
References
1. Crichton RR (2001) Inorganic Biochemistry of Iron Metabolism. Wiley, J. and Sons, 
Ltd, Chichester and New York
2. Ha Y, Shi D, Small GW, Theil EC, Allewell NM (1999) J Biol Inorg Chem 4:243-256
3. Sun S, Arosio P, Levi S, Chasteen ND (1993) Biochemistry 32:9362-9369
4. Bauminger ER, Harrison PM, Hechel D, Hodson NW, Nowik I, Treffry A, Yewdall SJ 
(1993) Biochem J 296 ( Pt 3):709-719
5. Lawson DM, Artymiuk PJ, Yewdall SJ, Smith JM, Livingstone JC, Treffry A,
Luzzago A, Levi S, Arosio P, Cesareni G (1991) Nature 349:541-544
6. Hempstead PD, Hudson AJ, Artymiuk PJ, Andrews SC, Banfield MJ, Guest JR, 
Harrison PM (1994) FEBS Lett 350:258-262
7. Stillman TJ, Hempstead PD, Artymiuk PJ, Andrews SC, Hudson AJ, Treffry A, Guest 
JR, Harrison PM (2001) J Mol Biol 307:587-603
8. Toussaint L, Bertrand L, Hue L, Crichton RR, Declercq JP (2007) J Mol Biol 365:440­
452
9. Macedo S, Romao CV, Mitchell E, Matias PM, Liu MY, Xavier AV, LeGall J, 
Teixeira M, Lindley P, Carrondo MA (2003) Nat Struct Biol 10:285-290
10. Sayers DE, Theil EC, Rennick FJ (1983) J Biol Chem 258:14076-14079
11. Strange R, Morante S, Stefanini S, Chiancone E, Desideri A (1993) Biochim Biophys 
Acta 1164:331-334
12. Heath SL, Charnock JM, Garner CD, Powell AK (1996) Chemistry - A European 
Journal 2:634-639
13. Hwang J, Krebs C, Huynh BH, Edmondson DE, Theil EC, Penner-Hahn JE (2003) 
Science 287:122-125
14. da Costa PN, Romao CV, LeGall J, Xavier AV, Melo E, Teixeira M, Saraiva LM 
(2001)Molecular Microbiology, pp. 217-227
15. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith, JA, Struhl K (1995) 
Current Protocols in Molecular Biology. New York: Greene Publishing Associates and Wiley 
Interscience
16. Prozzi D, Crichton RR, Davison J (1988) Febs Letters 234:61-64
17. Shatzman AR, Rosenberg M (1987) Hepatology 7:30S-35S
18. Hermes C, Gilberg E, Koch MHJ (1984) Nuclear Instruments & Methods in Physics 
Research Section a-Accelerators Spectrometers Detectors and Associated Equipment 
222:207-214
19. Pettifer RF, Hermes C (1985) Journal of Applied Crystallography 18:404-412
20. Nolting H-F, Hermes, C. (1992) EXPROG. EXAFS Data Reduction Package, EMBL 
Outstation Hamburg, Germany
21. Gurman SJ, Binsted N, Ross I (1986) Journal of Physics C-Solid State Physics 
19:1845-1861
22. Gurman SJ, Binsted N, Ross I (1984) J. Phys. C., Solid State Phys. 17:143-151
23. Rehr JJ, Booth CH, Bridges F, Zabinsky SI (1994) Physical Review B 49:12347­
12350
24. Krebs C, Edmondson DE, Huynh BH (2002) Methods Enzymol 354:436-454
25. Herold S, Lippard SJ (1997) J Am Chem Soc 119: 145-156
26. Rohrer JS, Islam QT, Watt GD, Sayers DE, Theil EC (1990) Biochemistry 29:259-264
27. Shulman RG, Eisenberger P, Blumberg WE, Stombaugh NA (1975) Proc. Natl. Acad. 
Sci. U.S.A. 72 4003-4007
34
1 28. Sayers DE, Stern EA, Herriott JR (1975) J. Chem. Phys. 64 427-428
2 29. Thorp HH (1992) Inorg. Chem. 31:1585-1588
3 30. Carrondo MA, Bento I, Matias PM, Lindley PF (2007) J Biol Inorg Chem 12:429-442
4 31. Harding MM (2001) Acta Crystallogr D Biol Crystallogr 57:401-411
5 32. Stenkamp RE, Sieker LC, Jensen LH (1983) Acta Cryst B39: 697-703.
6 33. Strange RW, Ellis M, Hasnain SS (2005) Coord Chem Rev 249: 197-208.
7 34. Mackle P, Garner CD, Ward RJ, Peters TJ (1991) Biochim Biophys Acta 1115:145-
8 150
9 35. Mijovilovich A, Meyer-Klaucke W (2003) J Synchrotron Radiat 10:64-68
10 36. Feiters MC, Eijkelenboom AP, Nolting HF, Krebs B, van den Ent FM, Plasterk RH,
11 Kaptein R, Boelens R (2003) J Synchrotron Radiat 10:86-95
12 37. Eggers-Borkenstein P, Priggemeyer S, Krebs B, Henkel G, Simonis U, Pettifer RF,
13 Nolting HF, Hermes C (1989) Eur J Biochem 186:667-675
14 38. Randall CR, Zang Y, True AE, Que L, Jr., Charnock JM, Garner CD, Fujishima Y,
15 Schofield CJ, Baldwin JE (1993) Biochemistry 32:6664-6673
16 39. Kröger M, Folli C, Walter O, Doring M (2006) Adv Synth Catal 348: 1908-1918
17 40. Darensbourg DJ, Wildeson JR, Yarbrough JC (2001) Organometallics 20: 4413-4417
18 41. Yang CY, Meagher A, Huynh BH, Sayers DE, Theil EC (1987) Biochemistry 26:497-
19
20 
21
503
35
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Figures 
Figure 1.
(a) Q141
P '  N
E27^°~?H 2 ) y E107
O—'FPa F,éB"~Ó-  ^
H65^-'N 0 ^ 0  Ó 
1 >  Y  o Y34
E62 >-O
E61
(b)
E56
E23^—Ó O O Ó—^E99
\  V  n ' '  Ó"'FveA F,eB'Ó
H59—,— N ( X / ó'N ^ H 1 3 5
T  N> T  <7 XN E132
(c)
3.0 C \
„  ^ 2.0 O  O 3.5
2.0 O n /  \  D
2.0 O- - ;Fe 3.8 FjbV — O
2.0 Ó  \  ¡ ''O
2.0 O - ^ O  3.5
3.0 C
(d)
3.0 C \
2.0 O 2T  0  3.8 ,O
Zn 4.0 ZnC
2.0 Ó  \  i  '0
2.0 0 ^  ^ 0  3.8
3.0 C
Figure 1. Schematic representation of ferroxidase site.
(a) H um an  H ferritin, adapted from ref. [8] (E61 is conserved and was implied in metal 
coordination in early crystallographic studies [5, 6]). (b) Oxidised D esulfovibrio desulfuricans 
bacterioferritin, adapted from ref. [9] structure A (E99 is asymmetric bidentate in the reduced 
structure B, and monodentate in the aerobically crystallised/cycled-oxidised structure C). (c) 
and (d), starting models for the EXAFS simulations of Fe- and Zn-loaded ferritins, 
respectively, with the numbers in red bold indicating the distance to the red bold metal atom.
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Figure 2. Fe K Edge of Fe-loaded ferritins, from low to high energy: blue, rHuHf-E107D; 
green, reduced DdBfr; orange, rHuHf-E27D/E107D; brown, rHuHf-E27D; grey, “wild type” 
rHuHf (K86Q); turquoise, Chelex®-treated DdBfr; red, oxidised DdBfr.
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er
Figure 3. k -weighted Fe K EXAFS (left panel) and corresponding phase-corrected Fourier 
transform (right) of D esulfovibrio desulfuricans bacterioferritin (DdBfr). Coloured traces, 
experimental: turquoise, Chelex®-treated; red, oxidised; green, reduced; black thin solid 
traces, corresponding simulations with the parameters listed in Table 1.
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Figure 4. k -weighted EXAFS (left panels) and corresponding phase-corrected Fourier
transform (right) of reduced D esulfovibrio desulfuricans bacterioferritin (DdBfr). (i) EXAFS 
simulation on the basis of the .pdb file related to the crystal structure of reduced wild type 
DdBfr [9], 1nf4 (distances in Table 2); (ii) major shells adjusted to the average EXAFS value 
found in the initial simulation given in trace (iv), Figure 3 and Table 1; (iii) simulation 
obtained by iterative refinement of the AEF and distance values, starting from the adjustment 
in (ii), resulting in the distances given in italic in Table 2; (iv) simulation based on the 
simplified model in Fig. 1c, refining to the parameters in Table 1.
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Figure 5
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Figure 5. Ferroxidase site in reduced DdBfr with Fe-ligand distances in A: A) as determined 
by crystallography [9], B) adjusted to give agreement with the EXAFS. Colour code: grey, 
carbon, red, oxygen; blue, nitrogen; orange, Fe; hydrogens are omitted for clarity. Green and 
blue distance values refer to FeA (left Fe ion) and FeB (right), respectively.
40
12
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Figure 6
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Figure 6. Zn K edge of Zn-loaded rH uH f (bold: blue rHuHf-E107D, colliding with orange: 
rHuHf-E27D/E107D; violet: rHuHf-E27D, colliding with green: “wild type” rHuHf (K86Q)) 
and Zn complexes (thin lines: light green, tetrakis(imidazole)Zn(II) diperchlorate (Zn(Im)4, 
tetrahedral 4-c.); orange, bis(acetato)bis(imidazole)Zn(II) (ZnIm2Äc2 , near tetrahedral 4-c.); 
red, zinc oxide (ZnO, tetrahedral 4-c.); dark green, bis(L-histidino)Zn(II) dehydrate (Zn(His)2 , 
tetrahedral 4-c.); turquoise, bis[(imidazol-2-yl-thiophen-2-yl)methanol]zinc(II) sulphate 
hydrate (Zn(ImThOH)2 , 5-c.); pink, triaquabis(N-benzoylglycinato)zinc(II) dihydrate 
(Zn(H2O)3 (BzGly)2 , 5-c.); brown, tetraaquabis(hydrogenmaleato)zinc(II) (Zn(mal)2 , 
octahedral 6-c.); see [36, 37] for details of models.
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3
Figure 7. k -weighted Zn K EXAFS (left panel) and corresponding phase-corrected Fourier 
transform (right) of rHuHf. Coloured traces, experimental: green, “wild type” rHuHf (K86Q); 
violet, rHuHf-E27D; orange, rHuHf-E27D/E 107D; blue, rHuHf-E107D; black thin solid 
traces, corresponding simulations with the parameters listed in Table 3.
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Figure 8. k3-weighted Fe K EXAFS (left panel) and corresponding phase-corrected Fourier 
transform (right) of rHuHf. Coloured traces, experimental: green, “wild type” rHuHf (K86Q); 
violet, rHuHf-E27D; orange, rHuHf-E27D/E 107D; blue, rHuHf-E107D; black thin solid 
traces, corresponding simulations with the parameters listed in Table 4.
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